IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS - ANVISA Registration 10287410803
Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287410803 and manufactured by VENTANA MEDICAL SYSTEM, INC. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Jun 08, 2034.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including CELL MARQUE CORPORATION, VENTANA MEDICAL SYSTEM, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
10287410803
25351124897200912
30280358000186
Company Information
Dates and Status
Jun 08, 2009
08/06/2034
09/18/2025 19:00:01
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA DE MARCADORES DE LINFOMAS E LEUCEMIAS
Not specified
80358430003
Oct 04, 2010
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA DE MARCADORES DE LINFOMAS E LEUCEMIAS
CELL MARQUE CORPORATION
80358430003
Oct 04, 2010
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990034
Jul 02, 2018
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
Not specified
10337990034
Jul 02, 2018
IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS
Família Marcador de Carcinoma de Linfoma e Leucemia
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.
80000230044
Dec 26, 2016
CELL MARQUE CORPORATION• United States of America
VENTANA MEDICAL SYSTEM, INC• United States of America
LEICA BIOSYSTEMS NEWCASTLE LTD• United Kingdom
AGILENT TECHNOLOGIES, INC.• United States of America
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.• Singapore
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Anti-CD8 (SP239) Rabbit Monoclonal Primary Antibody
VENTANA MEDICAL SYSTEM, INC
10287411688
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Anti-CD8 (SP239) Rabbit Monoclonal Primary Antibody
Not specified
10287411688
Mar 25, 2024
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
Not specified
10337990034
Jul 02, 2018
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
FAMÍLIA ANTICORPO PARA CARCINOMA DE LINFOMA E LEUCEMIA
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990034
Jul 02, 2018
IMUNOHISTOQUÍMICA - MARCADORES DE LINFOMAS E LEUCEMIAS
Família Marcador de Carcinoma de Linfoma e Leucemia
Not specified
80000230036
Dec 26, 2016